Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company focused on intratumoral (IT) cancer treatment. Its lead product candidate, INT230-6, combines cisplatin, vinblastine sulfate, and an amphiphilic molecule (SHAO) to disperse cytotoxic agents directly into solid tumors. The company is conducting Phase 3 trials in soft tissue sarcoma (INVINCIBLE-3) and Phase 2 trials in triple-negative breast cancer (INVINCIBLE-4), aiming to achieve local tumor killing and systemic immune activation.
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001567264-26-000024 | EDGAR | 88K words |
| 2025-03-13 | 2024-12-31 | 0001567264-25-000010 | EDGAR | 89K words |
| 2024-03-14 | 2023-12-31 | 0001628280-24-011207 | EDGAR | 81K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001567264-26-000059 | EDGAR | 14K words |
| 2025-11-06 | 2025-09-30 | 0001567264-25-000103 | EDGAR | 16K words |
| 2025-08-07 | 2025-06-30 | 0001567264-25-000077 | EDGAR | 15K words |
| 2025-05-13 | 2025-03-31 | 0001567264-25-000039 | EDGAR | 13K words |
| 2024-11-13 | 2024-09-30 | 0001567264-24-000052 | EDGAR | 14K words |
| 2024-08-08 | 2024-06-30 | 0001567264-24-000041 | EDGAR | 13K words |
| 2024-05-09 | 2024-03-31 | 0001567264-24-000010 | EDGAR | 12K words |
| 2023-11-13 | 2023-09-30 | 0001213900-23-085791 | EDGAR | 23K words |
| 2023-08-14 | 2023-06-30 | 0001213900-23-066740 | EDGAR | 20K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001567264-26-000061 | EDGAR | 3K words |
| 2026-03-27 | 0001567264-26-000025 | EDGAR | 3K words |
| 2026-03-23 | 0001567264-26-000021 | EDGAR | 1K words |
| 2026-03-06 | 0001567264-26-000014 | EDGAR | 1K words |
| 2026-03-05 | 0001567264-26-000011 | EDGAR | 1K words |
| 2026-02-13 | 0001567264-26-000007 | EDGAR | 1K words |
| 2025-12-05 | 0001567264-25-000111 | EDGAR | 1K words |
| 2025-12-04 | 0001567264-25-000109 | EDGAR | 1K words |
| 2025-11-06 | 0001567264-25-000104 | EDGAR | 3K words |
| 2025-10-31 | 0001628280-25-047855 | EDGAR | 1K words |
90 total filings indexed. 68 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001567264 |
| Ticker | INTS |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.intensitytherapeutics.com |
| Listed | 2023-06-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/INTS (~200 tokens, structured JSON with cryptographic provenance)